OUE Healthcare Valuation

Is 5WA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5WA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 5WA (SGD0.03) is trading below our estimate of fair value (SGD0.35)

Significantly Below Fair Value: 5WA is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5WA?

Key metric: As 5WA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 5WA. This is calculated by dividing 5WA's market cap by their current earnings.
What is 5WA's PE Ratio?
PE Ratio	49.2x
Earnings	S$2.44m
Market Cap	S$119.96m

5WA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.8x
Enterprise Value/EBITDA	11.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 5WA's PE Ratio compare to its peers?

The above table shows the PE ratio for 5WA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	32.6x
40T ISEC Healthcare	16.4x	n/a	S$227.2m
EHG Econ Healthcare (Asia)	7.2x	n/a	S$58.5m
A50 Thomson Medical Group	80.5x	14.4%	S$1.2b
BSL Raffles Medical Group	26.2x	12.6%	S$1.6b
5WA OUE Healthcare	49.2x	n/a	S$120.0m

Price-To-Earnings vs Peers: 5WA is expensive based on its Price-To-Earnings Ratio (49.2x) compared to the peer average (32.6x).

Price to Earnings Ratio vs Industry

How does 5WA's PE Ratio compare vs other companies in the Asian Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 5WA is expensive based on its Price-To-Earnings Ratio (49.2x) compared to the Asian Healthcare industry average (21.2x).

Price to Earnings Ratio vs Fair Ratio

What is 5WA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5WA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	49.2x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 5WA's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

IHH Healthcare Berhad

RM 63.4b

An investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Turkey, Europe, and internationally.

Q0F

RM 2.15

-1.4%

29.5%

Yunnan Energy International

HK$209.3m

An investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, Hong Kong, Macau, Oceania, Asia, and internationally.

T43

HK$0.075

n/a

Econ Healthcare (Asia)

S$58.5m

An investment holding company, engages in the operation of medicare centers and nursing homes for eldercare in Singapore, Malaysia, and China.

EHG

S$0.22

4.8%

10.0%